Note that, although further exploration in a larger cohort of these biomarkers across a broader range of liver conditions could clarify their specificity and utility in differential diagnosis, the score incorporating Gal-9 and sTim-3 levels was also able to discriminate between PAHUA and AIH patients in both discovery and validation cohorts. Here, LGALS9 is linked to autoimmune hepatitis.